Company intelligence / Profile preview

Beijing Runde Kang Pharmaceutical Technology

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Rundekang Pharmaceutical Technology is a China-based pharmaceutical company focused on the research, development, and technical service of chemical drugs. The company specializes in the development of high-end generic drugs and improved new drugs, offering services that range from pharmaceutical R&D to technology transfer and registration support. Their portfolio primarily covers therapeutic areas such as cardiovascular health, metabolic diseases, and anti-infectives. By leveraging its R&D capabilities, the company aims to provide high-quality, affordable therapeutic solutions to the Chinese domestic market.

Therapeutic areas: EndocrinologyCardiovascularNeurologyInfectious Diseases
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Beijing Runde Kang Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Runde Kang Pharmaceutical Technology.

Explore the full profile